Fourpath Capital Management’s MetLife MET Stock Holding History

Fourpath Capital Management’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-717	Closed	-$59.1K	–	555
2024 Q3	$59.1K	Buy	+717	New	+$53.6K	0.01%	323

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fourpath Capital Management's MET Position: Q4 2024 in Review

Fourpath Capital Management sold out of MetLife (MET) in Q4 2024, closing a stake of 717 shares — an estimated $59.1K sold.

Fourpath Capital Management first reported a position in MET in Q3 2024 and held it in 1 quarter. The position peaked at $59.1K in Q3 2024. 1,401 funds tracked by Wall St. Rank hold MET as of Q4 2024.

Fourpath Capital Management reported no remaining MetLife position as of Q4 2024 after selling out during the quarter.
Fourpath Capital Management sold 717 MetLife shares in Q4 2024, an estimated $59.1K.
Fourpath Capital Management first reported a position in MetLife in Q3 2024 and held it in 1 quarter.
Fourpath Capital Management's MetLife position peaked at $59.1K in Q3 2024.
1,401 funds tracked by Wall St. Rank held MetLife as of Q4 2024.

Based on Fourpath Capital Management's 13F filing for Q4 2024, filed 24 Jan 2025.